Endometriosis: alternative methods of medical treatment

• Published in: International journal of women's health Vol. 7; no. default; pp. 595 - 603
• Main Authors: Muñoz-Hernando, Leticia, Muñoz-Gonzalez, Jose L, Marqueta-Marques, Laura, Alvarez-Conejo, Carmen, Tejerizo-García, Álvaro, Lopez-Gonzalez, Gregorio, Villegas-Muñoz, Emilia, Martin-Jimenez, Angel, Jiménez-López, Jesús S
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01.01.2015; Taylor & Francis Ltd; Dove Medical Press
• Subjects: Analysis; Birth control; Bone density; Care and treatment; Clinical trials; Development and progression; Drug dosages; Endometriosis; Estrogen antagonists; Estrogens; Gynecology; Infertility; Laparoscopy; Medical treatment; Methods; Nonsteroidal anti-inflammatory drugs; Obstetrics; Original Research; Pain; Patient outcomes; Physiological aspects; Surgery; Tumor necrosis factor-TNF; Womens health; United States; Spain; antiangiogenic factors; pharmacological treatment options; hormonal treatments; anti-TNF-α; endometrial tissue; GnRH antagonists; aromatase inhibitors; selective progesterone receptor modulators
• ISSN: 1179-1411; 1179-1411
• DOI: 10.2147/IJWH.S78829

Endometriosis is an inflammatory estrogen-dependent disease defined by the presence of endometrial glands and stroma at extrauterine sites. The main purpose of endometriosis management is alleviating pain associated to the disease. This can be achieved surgically or medically, although in most women a combination of both treatments is required. Long-term medical treatment is usually needed in most women. Unfortunately, in most cases, pain symptoms recur between 6 months and 12 months once treatment is stopped. The authors conducted a literature search for English original articles, related to new medical treatments of endometriosis in humans, including articles published in PubMed, Medline, and the Cochrane Library. Keywords included "endometriosis" matched with "medical treatment", "new treatment", "GnRH antagonists", "Aromatase inhibitors", "selective progesterone receptor modulators", "anti-TNF α", and "anti-angiogenic factors". Hormonal treatments currently available are effective in the relief of pain associated to endometriosis. Among new hormonal drugs, association to aromatase inhibitors could be effective in the treatment of women who do not respond to conventional therapies. GnRH antagonists are expected to be as effective as GnRH agonists, but with easier administration (oral). There is a need to find effective treatments that do not block the ovarian function. For this purpose, antiangiogenic factors could be important components of endometriosis therapy in the future. Upcoming researches and controlled clinical trials should focus on these drugs.